AdaptHealth Corp.는 자회사 네트워크와 함께 미국 전역에서 가정용 의료 장비(HME), 용품 및 관련 서비스를 포괄적으로 제공한다. 이 회사는 수면 치료에 특화되어 있으며, ...
AdaptHealth Corp.는 자회사인 AdaptHealth LLC가 2028년 만기 6.125% 우선채권(시니어 노트) 3억2500만 달러 전액을 상환할 계획이라고 발표했다. 이번 상환은 기존의 지연 인출(딜레이드 드로우) 정기대출 시설을 통한 차입으로부터 충분한 순유입자금을 확보하는 조건부로 진행된다. 상환은 2026년 8월 1일에 이뤄질 것으로 예상되며, 2026년 8월 3일에 지급이 이뤄진다. 이후에는 해당 채권에 대한 이자 начис이 중단될 예정이다.
AdaptHealth(AHCO)는 2028년 만기 6.125% 우선채권 전액 3억2500만 달러를 상환할 계획을 밝혔다. 이번 상환은 지연 인출 정기대출로부터 충분한 자금을 확보하는 데 달려 있다. 상환일은 2026년 8월 1일로 예상되며, 지급은 2026년 8월 3일까지 이뤄질 예정이다.
AdaptHealth는 6월에 발생한 사이버공격으로 인해 보험 청구를 위한 비밀번호 파일과 일부 개인식별건강정보를 포함한 환자 데이터가 노출되었다고 밝혔다. 회사는 영향을 받은 시스템에는 해당 데이터가 저장되어 있지 않기 때문에 사회보장번호나 금융 계좌 정보는 손상되지 않았다고 전했다. 이번 침해는 제3자 계약업체에 대한 성공적인 소셜 엔지니어링 공격으로 인한 것으로 설명되었으며, AdaptHealth는 차단 조치(컨테인먼트)를 시행하고 조사를 계속하고 있다.
AdaptHealth는 최근 사이버공격으로 인해 환자 데이터(개인식별정보 및 보호되는 건강정보)가 도난당했다고 공개했다. 이번 사건은 제3자 계약업체의 사용자 세션에 대한 소셜 엔지니어링 공격을 포함했으며, 그 결과 클라우드 기반 비즈니스 애플리케이션과 외부 EHR 포털에 대한 무단 액세스가 가능해졌다. 도난된 데이터의 전체 범위와 규모는 아직 조사 중이지만, AdaptHealth는 사회보장번호와 금융 계좌 정보는 영향을 받은 시스템에 저장되어 있지 않았고 해당 사건이 운영에 실질적인 영향을 미치지 않았다고 확인했다.
AdaptHealth의 최고상업책임자(Chief Commercial Officer) 러셀 E. 슈스터 3세(Russell E. Schuster III)는 2026년 7월 1일 1주당 $10.44에 보통주(Common Stock) 11,275주를 매도했습니다. 이번 거래는 2026년 3월 2일 채택된 사전 약정 Rule 10b5-1 거래 계획에 따라 자동으로 진행된 장내 매도(open-market sale)입니다. 매도 이후 슈스터 3세는 125,263주를 직접 보유하고 있습니다.
AdaptHealth Corp.는 자회사인 AdaptHealth LLC가 2028년 만기 6.125% 우선채권(시니어 노트) 3억2500만 달러 전액을 상환할 계획이라고 발표했다. 이번 상환은 기존의 지연 인출(딜레이드 드로우) 정기대출 시설을 통한 차입으로부터 충분한 순유입자금을 확보하는 조건부로 진행된다. 상환은 2026년 8월 1일에 이뤄질 것으로 예상되며, 2026년 8월 3일에 지급이 이뤄진다. 이후에는 해당 채권에 대한 이자 начис이 중단될 예정이다.
AdaptHealth(AHCO)는 2028년 만기 6.125% 우선채권 전액 3억2500만 달러를 상환할 계획을 밝혔다. 이번 상환은 지연 인출 정기대출로부터 충분한 자금을 확보하는 데 달려 있다. 상환일은 2026년 8월 1일로 예상되며, 지급은 2026년 8월 3일까지 이뤄질 예정이다.
AdaptHealth는 6월에 발생한 사이버공격으로 인해 보험 청구를 위한 비밀번호 파일과 일부 개인식별건강정보를 포함한 환자 데이터가 노출되었다고 밝혔다. 회사는 영향을 받은 시스템에는 해당 데이터가 저장되어 있지 않기 때문에 사회보장번호나 금융 계좌 정보는 손상되지 않았다고 전했다. 이번 침해는 제3자 계약업체에 대한 성공적인 소셜 엔지니어링 공격으로 인한 것으로 설명되었으며, AdaptHealth는 차단 조치(컨테인먼트)를 시행하고 조사를 계속하고 있다.
AdaptHealth는 최근 사이버공격으로 인해 환자 데이터(개인식별정보 및 보호되는 건강정보)가 도난당했다고 공개했다. 이번 사건은 제3자 계약업체의 사용자 세션에 대한 소셜 엔지니어링 공격을 포함했으며, 그 결과 클라우드 기반 비즈니스 애플리케이션과 외부 EHR 포털에 대한 무단 액세스가 가능해졌다. 도난된 데이터의 전체 범위와 규모는 아직 조사 중이지만, AdaptHealth는 사회보장번호와 금융 계좌 정보는 영향을 받은 시스템에 저장되어 있지 않았고 해당 사건이 운영에 실질적인 영향을 미치지 않았다고 확인했다.
AdaptHealth의 최고상업책임자(Chief Commercial Officer) 러셀 E. 슈스터 3세(Russell E. Schuster III)는 2026년 7월 1일 1주당 $10.44에 보통주(Common Stock) 11,275주를 매도했습니다. 이번 거래는 2026년 3월 2일 채택된 사전 약정 Rule 10b5-1 거래 계획에 따라 자동으로 진행된 장내 매도(open-market sale)입니다. 매도 이후 슈스터 3세는 125,263주를 직접 보유하고 있습니다.
집단소송 전문 로펌 샤미스 & 젠틸 P.A.(Shamis & Gentile P.A.)가 AdaptHealth Corp.에서 발생한 데이터 침해를 조사하고 있습니다. 해당 침해로 보험 청구 비밀번호, 개인정보(PII), 보호되는 건강정보(PHI) 등 민감한 소비자 정보가 노출됐습니다. 침해 사실은 2026년 6월 27일 공개됐으며, 피해를 입은 개인은 보상을 받을 자격이 있을 수 있습니다. 2012년에 설립된 AdaptHealth는 가정용 의료 장비와 서비스를 제공합니다.
AdaptHealth Corp. CCO 러셀 E. 슈스터 3세(Russell E. Schuster III)는 회사 주식 11,275주를 총 $117,711에 매도했습니다. 매도는 Rule 10b5-1 거래 계획을 통해 이뤄졌습니다. 최근의 부진한 실적에도 불구하고, 애널리스트들은 올해 AdaptHealth의 수익성을 전망하고 있으며, Truist Securities는 "매수(Buy)" 등급을 유지하고 있습니다.
가정 의료 장비 제공의 유력 업체인 AdaptHealth Corp.는 2026년 6월 27일 미국 증권거래위원회(U.S. Securities and Exchange Commission)에 데이터 침해를 보고했습니다. 이번 사건으로 보험 청구 비밀번호, 개인정보(PII), 보호되는 건강정보(PHI) 등 환자 비밀번호가 잠재적으로 노출됐을 수 있습니다. 침해의 구체적 내용(영향을 받은 개인 수와 침해 방식 포함)은 공개되지 않았지만, 당사자들은 추가 지침과 보호 서비스를 위해 AdaptHealth의 직접적인 커뮤니케이션을 주의 깊게 확인하라고 권고받고 있습니다.
AdaptHealth has disclosed a data breach affecting personally identifiable information, protected health information, and insurance billing account passwords. This incident, caused by a social engineering attack on a third-party contractor's account, may lead to a class action lawsuit. Attorneys are seeking individuals impacted by the breach to investigate potential claims for compensation and to ensure AdaptHealth implements stronger data protection measures.
AdaptHealth Corp. (NASDAQ: AHCO) is investigating a cybersecurity incident that led to unauthorized access to its cloud-based business applications, including patient management systems, and the exfiltration of data. The company confirmed that a social engineering attack on a third-party contractor's user session exposed insurance billing passwords and patient identifiable/protected health information, though Social Security numbers and financial account details were not compromised. AdaptHealth has contained the incident and is continuing its investigation into the full scope and financial impact.
The article analyzes Adapthealth Corp. (NASDAQ: AHCO) based on AI models, indicating a strong overweight bias across all time horizons due to an oscillating pattern. It outlines three distinct trading strategies: a Long Position, a Momentum Breakout, and a Short Risk Hedging strategy, each with specific entry zones, targets, and stop losses. The analysis also provides multi-timeframe signal strength, support, and resistance levels.
AdaptHealth Corp. experienced a cybersecurity breach involving a third-party contractor, exposing patient and internal systems data but not Social Security numbers or financial accounts. While the stock's reaction has been muted, the incident highlights increased operational and regulatory risks. Investors should consider how this data breach shapes AdaptHealth's investment narrative, particularly concerning operational resilience and technology risk management.
This article provides a discussion forum for AdaptHealth (AHCO) stock. It serves as a platform for investors and interested parties to share opinions and insights regarding the company's performance and future outlook. The content is primarily user-generated discussion.
Faruqi & Faruqi, LLP is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) following allegations that the company misrepresented its organic growth trajectory and materially overstated its financial prospects. The lawsuit highlights a report from Jehoshaphat Research claiming AdaptHealth manipulated past organic growth numbers without disclosure, leading to a significant drop in its stock price on July 19, 2021. Investors who suffered losses exceeding $50,000 are encouraged to contact the firm by the September 27, 2021 deadline to discuss lead plaintiff options.
AdaptHealth, a publicly traded healthcare company, has reported a material cybersecurity incident to the SEC involving unauthorized access and exfiltration of patient data. The breach originated from a social engineering attack on a third-party contractor, leading to the compromise of internal patient management and document storage systems. While the investigation is ongoing and the full extent of the data theft is unknown, the incident is considered material due to the potential volume of at-risk data, and the ShinyHunters threat group has reportedly claimed responsibility, threatening to leak the data if ransom is not paid.
AdaptHealth (ADPT) announced that some of its computer systems were affected by a cybersecurity attack in mid-June. The company stated that the potential theft of data is "material" due to its nature and volume. Following this news, AdaptHealth's shares were down 7%.
This article from Investing.com is a Form 144 filing for AdaptHealth Corp., dated July 1. It emphasizes the risks associated with trading financial instruments and cryptocurrencies, advising investors to be fully informed and seek professional advice. The content also notes that data provided may not be real-time or accurate and is for indicative purposes only.
This article from Investing.com announces the filing of Form 144 for AdaptHealth Corp. on July 1st. Form 144 is a notice of the intent to sell restricted securities. The brief notice provides a direct update regarding this financial filing.
This page provides access to AdaptHealth Corp.'s financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K, allowing users to evaluate the company's financial performance. It lists a chronological overview of earnings reports, corporate events, and conference transcripts from 2023 to 2026, highlighting key business updates and strategic developments for AHCO.
This article from Investing.com is a placeholder announcement for a Form 4 filing by Adapthealth Corp on June 26th. It provides no significant details about the filing itself but is surrounded by extensive financial market data, news headlines, and promotional content common to financial news platforms. The core content is simply the notification of the Form 4.
This article provides a brief financial update on AdaptHealth Corp. (NASDAQ: AHCO), specifically focusing on its enterprise value to EBIT forward metric. The information is presented within the context of TradingView's platform, indicating that detailed financial data for the company is available there.
This article provides an overview of AdaptHealth Corp. (NASDAQ: AHCO) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals and estimates, revenue, and earnings reports, confirming the next earnings date is August 11, 2026. The information is presented to help investors understand the company's financial health and stock outlook.
AdaptHealth Corp. director Gregory Belinfanti was granted 18,999 restricted stock units (RSUs) at no purchase price, increasing his direct holdings to 104,269 shares. This transaction, categorized as a grant/award, was reported in a Form 4 filing and indicates an increase in his equity position, with the RSUs settling in common stock upon vesting. The filing does not indicate any stock sales by Belinfanti.
AdaptHealth Corp. director David Solomon Williams III was granted 18,999 restricted stock units (RSUs) on June 24, 2026, as part of his equity-based compensation. These RSUs were valued at $0.00 per share and will convert to common stock upon vesting. Following this grant, Williams holds a total of 64,044 shares of AdaptHealth common stock, reflecting a compensation-related acquisition rather than an open-market transaction.
AdaptHealth (AHCO) director Bradley J. Coppens was granted 18,999 restricted stock units (RSUs) of Common Stock, as reported in a Form 4 filing. These RSUs will be settled in common stock upon vesting and were awarded as compensation with a price of $0.00 per share. Following this transaction, Coppens directly holds a total of 96,345 shares of AdaptHealth.
AdaptHealth (AHCO) director Kenneth A. Samet has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The filing indicates his role as a director but reports no stock transactions or derivative positions at this time. This Form 3 establishes a baseline of his current beneficial ownership, providing transparency without immediate implications of stock changes.
AdaptHealth director Terence J. Connors was granted 18,999 restricted stock units (RSUs) on June 24, 2026, which will be settled in common stock upon vesting. This transaction, reported via a Form 4 filing, increases his direct holding to 95,262 shares of AdaptHealth Common Stock. The RSUs were awarded as compensation rather than purchased, aligning his equity with the company's success.
AdaptHealth Corp. director Susan T. Weaver was granted 18,999 restricted stock units (RSUs) of common stock at a price of $0.00 per share, as reported in a recent Form 4 filing. This award increases her direct holdings to 40,345 shares, with an additional 73,472 shares held indirectly through an Irrevocable Trust. The RSUs will convert to common stock upon vesting and were awarded as compensation rather than an open-market transaction.
This article displays the "Price to sales forward" metric for AdaptHealth Corp. (NASDAQ: AHCO) on the TradingView platform. It presents financial data for the company within the health services sector. The content itself seems to be a snapshot of a financial data point rather than an analytical piece.
Truist Securities reiterated its positive stance on AdaptHealth (AHCO) after recent meetings with management, reinforcing confidence in its governance and leadership following the 2026 annual stockholder meeting. While boosting sentiment, this commentary doesn't fundamentally alter the core investment narrative, which still focuses on achieving revenue guidance, improving margins, and successful acquisition integration. Investors should monitor ongoing losses, execution risks in acquisitions, and the use of the new credit facility.
This article provides the "Price to earnings forward" financial data for AdaptHealth Corp. (AHCO) under the BOATS (Blue Ocean Alternative Trade System) listing on TradingView. It indicates that the market is currently closed, and no trades have occurred for this metric. The page includes various navigation and information sections typical of a financial data platform.
Truist Securities reiterated its positive stance on AdaptHealth (AHCO) after meetings with management, and the company's annual stockholder meeting approved key governance items, boosting confidence in its leadership. While these developments reinforce the investment narrative regarding management and governance, they do not fundamentally alter the near-term catalysts or risks for investors. AdaptHealth still faces challenges such as ongoing losses, execution risks with acquisitions, and the efficient use of its new credit facility, which remain central concerns for investors.
This article provides a brief financial overview for AdaptHealth Corp. (NASDAQ: AHCO) focusing on its enterprise value to revenue forward. It appears to be a stub or a placeholder from TradingView, indicating financial data without presenting specific figures. The content is primarily navigational and copyright information from the platform.
Shares of AdaptHealth (AHCO) rose 2.5% after a Truist Securities analyst reiterated a Buy rating and a $14 price target, expressing confidence in the company after management meetings. This positive outlook appears to have boosted investor sentiment despite a significant loss reported in the fourth quarter of 2025. The stock is up 3% year-to-date but remains well below its 52-week high, and long-term investors since 2021 would have seen a substantial decline in value.
This article focuses on the "Enterprise value to revenue forward" metric for AdaptHealth Corp. (AHCO). It indicates that the company's financial data and specifics regarding this metric can be found within the TradingView platform under the BOATS:AHCO ticker. The article itself does not provide the specific value or analysis of this metric but serves as a header or link to such information.
The article analyzes Adapthealth Corp. (NASDAQ: AHCO) using AI models, highlighting weak near-term sentiment but strong long-term potential. It details an exceptional risk-reward setup targeting a 12.5% gain, alongside three distinct trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored to different risk profiles. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
Shares of AdaptHealth Corp. (AHCO) increased by 2.5% after a Truist Securities analyst reiterated a Buy rating and a $14 price target, boosting investor confidence. This positive movement follows an earlier period of volatility, including a significant drop four months prior due to a substantial GAAP loss despite a revenue beat. The stock is up 3% year-to-date, but still significantly below its 52-week high, indicating a challenging long-term performance for early investors.
Truist Securities has reiterated its Buy rating and $14.00 price target for AdaptHealth (NASDAQ:AHCO), citing solid core trends and progress on a recent capitated contract. The firm sees further contract wins and efficiency benefits from technology investments. AdaptHealth's stock is considered undervalued, with analysts predicting profitability this year.
AdaptHealth Corp. shareholders approved all proposals at their annual meeting, including the election of nine directors for one-year terms. They also ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the compensation of named executive officers. These decisions follow AdaptHealth's recent first-quarter 2026 earnings report, which indicated a revenue beat but an EPS miss.
AdaptHealth Corp. shareholders have approved all proposals at their recent annual meeting, including the election of nine directors and the ratification of KPMG LLP as their independent registered public accounting firm for the fiscal year ending December 31, 2026. They also approved a non-binding advisory vote on executive officer compensation. These decisions follow AdaptHealth's Q1 2026 earnings report, which showed missed EPS but exceeded revenue expectations, impacting investor sentiment.
This article from Investing.com is a straightforward announcement regarding an 8K filing by Adapthealth Corp for June 22. It provides the title of the filing and specifies the company and date without offering further details or analysis. The main purpose of the article appears to be reporting the existence of this SEC filing.
This article reports that Adapthealth Corp filed a Form 8K on June 22. It briefly mentions recent market performance for various indices, commodities, bonds, and stocks, and highlights trending stocks and investment challenges. The main focus is the SEC filing by Adapthealth Corp.
AdaptHealth Corp. (NASDAQ: AHCO) announced the results of its 2026 annual stockholders meeting. Shareholders elected nine directors, ratified KPMG LLP as the independent registered public accounting firm for fiscal year 2026, and approved the compensation for named executive officers on a non-binding advisory basis. The meeting had a significant quorum with 88.67% of voting power represented.
Adapthealth Corp (AHCO) currently has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have an average price target of $13.00 for AHCO, with a majority recommending a "Buy" based on ratings from 8 analysts. The company's expected revenue for the next quarter is $848.58M, and EPS is forecasted at $0.18 for the upcoming quarter.
This article analyzes Adapthealth Corp. (NASDAQ: AHCO) stock movements, indicating positive near-term sentiment while noting a weak mid-term bias within a long-term strong context. It highlights an exceptional 39.7:1 risk-reward setup, targeting an 11.9% gain against a 0.3% risk, and provides three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) tailored for different risk profiles.
AdaptHealth (AHCO) has underperformed for months, showing a small loss compared to the S&P 500's significant gain. StockStory recommends avoiding the stock due to flatlining revenue growth, declining EPS, and ineffective past growth initiatives with a low return on invested capital. Instead, they suggest investing in a dominant software business and highlight "Strong Momentum" stocks, noting past successes like Nvidia and Comfort Systems.
AdaptHealth Corp. appointed Daniel McFadden as COO, increasing his salary, as the company focuses on a new five-year, over US$1 billion capitated contract expected to add US$200 million in annual recurring revenue. This move signals the board's emphasis on operational execution to translate the significant revenue into consistent profitability, though risks remain regarding execution missteps and profit volatility. Investors are watching how the new leadership will manage the contract's ramp-up and integrate acquisitions to improve the company's financial health.
This article states that AdaptHealth (AHCO) is scheduled to report its earnings tomorrow. Investors and analysts will be keen to see the company's financial performance and outlook. The report will likely detail revenue, earnings per share, and other key financial metrics.
The article provides a technical analysis for Adapthealth Corp (AHCO), concluding with an overall "Strong Sell" consensus based on various indicators. It details the stock's performance against moving averages, its RSI and MACD status, and identifies key support and resistance levels. The analysis indicates that AHCO is currently trading below its 200-day moving average, suggesting a bearish long-term trend.
This article indicates that AdaptHealth (AHCO) is scheduled to report its earnings tomorrow. It suggests that investors should be aware of the upcoming financial release. The content implies an anticipation of what the earnings report might reveal.
